These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20405181)

  • 41. Intravenous immunoglobulin treatment in lower motor neuron disease associated with highly raised anti-GM1 antibodies.
    van den Berg LH; Franssen H; Van Doorn PA; Wokke JH
    J Neurol Neurosurg Psychiatry; 1997 Nov; 63(5):674-7. PubMed ID: 9408114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic options.
    Meuth SG; Kleinschnitz C
    Eur Neurol; 2010; 63(4):193-204. PubMed ID: 20150737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Analysis of the clinical and electrophysiological characteristics of multifocal motor neuropathy].
    Wang HF; Yang F; Cui F; Chen ZH; Ling L; Huang XS
    Zhonghua Nei Ke Za Zhi; 2017 Nov; 56(11):842-845. PubMed ID: 29136715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Childhood-Onset Multifocal Motor Neuropathy with IgM Antibodies to Gangliosides GM1: A Case Report with Poor Outcome.
    Pro S; Ursitti F; Pruneddu GL; Di Capua M; Valeriani M
    Neuropediatrics; 2021 Oct; 52(5):406-409. PubMed ID: 33511596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multifocal motor neuropathy with conduction block and Campylobacter jejuni.
    White JR; Sachs GM; Gilchrist JM
    Neurology; 1996 Feb; 46(2):562-3. PubMed ID: 8614535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous immunoglobulin treatment on anti-GM1 antibodies associated neuropathies inhibits cholera toxin and galectin-1 binding to ganglioside GM1.
    Peng W
    Immunol Lett; 2012 Apr; 143(2):146-51. PubMed ID: 22289946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A practical definition of conduction block in IvIg responsive multifocal motor neuropathy.
    Ghosh A; Busby M; Kennett R; Mills K; Donaghy M
    J Neurol Neurosurg Psychiatry; 2005 Sep; 76(9):1264-8. PubMed ID: 16107364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Multifocal motor neuropathy with persistent conduction blocks. A chronic immune-mediated neuropathy].
    Léger JM; Vargas S
    Presse Med; 2006 Apr; 35(4 Pt 2):720-7. PubMed ID: 16614621
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multifocal motor neuropathy.
    Van Asseldonk JT; Franssen H; Van den Berg-Vos RM; Wokke JH; Van den Berg LH
    Lancet Neurol; 2005 May; 4(5):309-19. PubMed ID: 15847844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fulminant multifocal motor neuropathy: a report of two cases.
    Galassi G; Girolami F; Ariatti A; Monelli M; Sola P
    Int J Neurosci; 2012 Jul; 122(7):395-400. PubMed ID: 22332970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Multifocal motor neuropathy].
    Traba A; Esteban A
    Rev Neurol; 2000 Mar 16-31; 30(6):519-25. PubMed ID: 10863724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distal lower motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide.
    Pestronk A; Lopate G; Kornberg AJ; Elliott JL; Blume G; Yee WC; Goodnough LT
    Neurology; 1994 Nov; 44(11):2027-31. PubMed ID: 7969954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
    Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
    J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
    Busby M; Donaghy M
    J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Childhood-Onset Multifocal Motor Neuropathy With Immunoglobulin M Antibodies to Gangliosides GM1 and GM2: A Case Report and Review of the Literature.
    Ishigaki H; Hiraide T; Miyagi Y; Hayashi T; Matsubayashi T; Shimoda A; Kusunoki S; Fukuda T
    Pediatr Neurol; 2016 Sep; 62():51-7. PubMed ID: 27400822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Long-term follow-up of multifocal motor neuropathy with conduction block under intravenous immunoglobulin].
    Delmont E; Azulay JP; Uzenot D; Attarian S; Verschueren A; Pouget J
    Rev Neurol (Paris); 2007 Jan; 163(1):82-8. PubMed ID: 17304176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies.
    Vlam L; van der Pol WL; Cats EA; Straver DC; Piepers S; Franssen H; van den Berg LH
    Nat Rev Neurol; 2011 Nov; 8(1):48-58. PubMed ID: 22105211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Do GM1 antibodies induce demyelination?
    Lange DJ; Trojaborg W
    Muscle Nerve; 1994 Jan; 17(1):105-7. PubMed ID: 8264688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum IgM anti-GM1 ganglioside antibodies in lower motor neuron syndromes.
    Niebroj-Dobosz I; Janik P; Kwieciński H
    Eur J Neurol; 2004 Jan; 11(1):13-6. PubMed ID: 14692882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment.
    Van den Berg-Vos RM; Franssen H; Wokke JH; Van den Berg LH
    Brain; 2002 Aug; 125(Pt 8):1875-86. PubMed ID: 12135977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.